121 related articles for article (PubMed ID: 36941195)
1. Temporal validation of the Australian estimated post-transplant survival score.
Irish GL; Campbell S; Kanellis J; Wyburn K; Clayton PA
Nephrology (Carlton); 2023 May; 28(5):292-298. PubMed ID: 36941195
[TBL] [Abstract][Full Text] [Related]
2. External validation of the estimated posttransplant survival score for allocation of deceased donor kidneys in the United States.
Clayton PA; McDonald SP; Snyder JJ; Salkowski N; Chadban SJ
Am J Transplant; 2014 Aug; 14(8):1922-6. PubMed ID: 24903739
[TBL] [Abstract][Full Text] [Related]
3. [Patient survival scale after kidney transplant from deceased donors in Veracruz, Mexico].
Martínez-Mier G; Soto-Miranda E; Moreno-Ley PI; Méndez-López MT; Budar-Fernández LF; Ávila-Pardo SF; Aguilar-Sandoval EG; Zilli-Hernández S; Lajud-Barquín F; Vega-Rojano L; Coello-Torres G
Rev Med Inst Mex Seguro Soc; 2019 May; 57(3):149-155. PubMed ID: 31995339
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Clinical Outcomes Among Deceased Donor Kidney Transplant Recipients Before and After Utilizing Estimated Posttransplant Survival Score for Kidneys Allocation in Malaysia.
Ng YM; Lim YS; Ee LW; Fong VK; Low CL; Yee SY; Abdul Wahab MZ; Wong HS; Yahya R
Transplant Proc; 2022 Mar; 54(2):278-281. PubMed ID: 35105465
[TBL] [Abstract][Full Text] [Related]
5. Assessing survival post-kidney transplantation in Australia: A multivariable prediction model.
McMichael LC; Gulyani A; Clayton PA
Nephrology (Carlton); 2024 Mar; 29(3):143-153. PubMed ID: 38014653
[TBL] [Abstract][Full Text] [Related]
6. External validation of the US and UK kidney donor risk indices for deceased donor kidney transplant survival in the Australian and New Zealand population.
Clayton PA; Dansie K; Sypek MP; White S; Chadban S; Kanellis J; Hughes P; Gulyani A; McDonald S
Nephrol Dial Transplant; 2019 Dec; 34(12):2127-2131. PubMed ID: 31157885
[TBL] [Abstract][Full Text] [Related]
7. Validation of a survival benefit estimator tool in a cohort of European kidney transplant recipients.
Coca A; Arias-Cabrales C; Valencia AL; Burballa C; Bustamante-Munguira J; Redondo-Pachón D; Acosta-Ochoa I; Crespo M; Bustamante J; Mendiluce A; Pascual J; Pérez-Saéz MJ
Sci Rep; 2020 Oct; 10(1):17109. PubMed ID: 33051519
[TBL] [Abstract][Full Text] [Related]
8. Association of Race and Ethnicity With High Longevity Deceased Donor Kidney Transplantation Under the US Kidney Allocation System.
Asfour NW; Zhang KC; Lu J; Reese PP; Saunders M; Peek M; White M; Persad G; Parker WF
Am J Kidney Dis; 2024 Apr; ():. PubMed ID: 38636649
[TBL] [Abstract][Full Text] [Related]
9. A model for calculating the long-term estimated post-transplant survival of deceased donor liver transplant patients.
Malamon JS; Jackson WE; Saben JL; Conzen K; Schold JD; Pomposelli JJ; Pomfret EA; Kaplan B
EBioMedicine; 2023 Apr; 90():104505. PubMed ID: 36870199
[TBL] [Abstract][Full Text] [Related]
10. First Asian Kidney Donor Profile Index (KDPI) and Estimated Post-Transplant Survival (EPTS) models, with validation against US models in Thai population.
Larpparisuth N; Nivatvongs S; Ingsathit A; Noppakun K; Lumpaopong A; Townamchai N; Pongsakul C; Attajarusit Y; Supaporn T; Premasathian N
Clin Transplant; 2022 Mar; 36(3):e14560. PubMed ID: 34902188
[TBL] [Abstract][Full Text] [Related]
11. Graft and Patient Survival in Kidney Transplant with Deceased Donor Using KDRI (Kidney Donor Risk Index), KDPI (Kidney Donor Profile Index), and EPTS (Estimated Post-Transplant Survival) in Colombia.
Vanin A A; Valderrama Cometa LA; Acuña Roldan CF; Alhajj NA; Devia Santacruz CJ
Ann Transplant; 2023 Aug; 28():e940522. PubMed ID: 37525450
[TBL] [Abstract][Full Text] [Related]
12. Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor-recipient combination.
Bae S; Massie AB; Thomas AG; Bahn G; Luo X; Jackson KR; Ottmann SE; Brennan DC; Desai NM; Coresh J; Segev DL; Garonzik Wang JM
Am J Transplant; 2019 Feb; 19(2):425-433. PubMed ID: 29935051
[TBL] [Abstract][Full Text] [Related]
13. VO
Chakkera HA; Kaplan B; Budhiraja P; Behmen S; Fitz-Patrick D; Butterfield RJ
Clin Transplant; 2022 Feb; 36(2):e14517. PubMed ID: 34679190
[TBL] [Abstract][Full Text] [Related]
14. Regional Disparities in Transplantation With Deceased Donor Kidneys With Kidney Donor Profile Index Less Than 20% Among Candidates With Top 20% Estimated Post Transplant Survival.
Husain SA; King KL; Dube GK; Tsapepas D; Cohen DJ; Ratner LE; Mohan S
Prog Transplant; 2019 Dec; 29(4):354-360. PubMed ID: 31506000
[TBL] [Abstract][Full Text] [Related]
15. Development of predictive score for post-transplant survival based on pre-transplant recipient characteristics.
Koo TY; Lee J; Yang J
Korean J Transplant; 2021 Jun; 35(2):86-92. PubMed ID: 35769528
[TBL] [Abstract][Full Text] [Related]
16. Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System.
Sethi S; Najjar R; Peng A; Mirocha J; Vo A; Bunnapradist S; Jordan SC; Huang E
Am J Kidney Dis; 2019 May; 73(5):605-614. PubMed ID: 30929853
[TBL] [Abstract][Full Text] [Related]
17. Retroactive application of the new kidney allocation system to renal transplants performed in the ECD/SCD era.
Ramanathan R; Gupta G; Kim J; Quinn K; Behnke M; Kang L; Sharma A
Clin Transplant; 2015 Dec; 29(12):1148-55. PubMed ID: 26436727
[TBL] [Abstract][Full Text] [Related]
18. Kidney Transplant Outcomes in elderly Recipients: An Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry Study.
Doucet BP; Cho Y; Campbell SB; Johnson DW; Hawley CM; Teixeira-Pinto ARM; Isbel NM
Transplant Proc; 2021; 53(6):1915-1926. PubMed ID: 34275599
[TBL] [Abstract][Full Text] [Related]
19. Continuous allocation: The problem with EPTS and pediatric kidney candidates.
Engen RM; Weiss S; Peterson CG
Pediatr Transplant; 2023 Nov; 27(7):e14608. PubMed ID: 37697939
[TBL] [Abstract][Full Text] [Related]
20. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
Trials; 2020 May; 21(1):428. PubMed ID: 32450917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
